On Thursday, Opko Health Inc (NASDAQ: OPK) opened at On Thursday, remained unchanged from the last session, before settling in for the closing price of $1.42. Price fluctuations for OPK have ranged from $1.15 to $2.04 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 1.59%. Company’s average yearly earnings per share was noted -277.08% at the time writing. With a float of $303.33 million, this company’s outstanding shares have now reached $671.55 million.
The extent of productivity of a business whose workforce counts for 2997 workers is very important to gauge. In terms of profitability, gross margin is 24.77%, operating margin of -21.32%, and the pretax margin is -1.45%.
Opko Health Inc (OPK) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Diagnostics & Research industry is another important factor to consider. The insider ownership of Opko Health Inc is 54.83%, while institutional ownership is 31.41%. The most recent insider transaction that took place on Apr 10 ’25, was worth 169,712. In this transaction CEO & Chairman of this company bought 125,000 shares at a rate of $1.36, taking the stock ownership to the 214,001,448 shares. Before that another transaction happened on Apr 08 ’25, when Company’s CEO & Chairman bought 125,000 for $1.48, making the entire transaction worth $184,650. This insider now owns 213,876,448 shares in total.
Opko Health Inc (OPK) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around -277.08% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.20% during the next five years compared to 32.04% growth over the previous five years of trading.
Opko Health Inc (NASDAQ: OPK) Trading Performance Indicators
Check out the current performance indicators for Opko Health Inc (OPK). In the past quarter, the stock posted a quick ratio of 3.13. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.34.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.09, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.22 in one year’s time.
Technical Analysis of Opko Health Inc (OPK)
The latest stats from [Opko Health Inc, OPK] show that its last 5-days average volume of 2.39 million was inferior to 4.67 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 32.48%. Additionally, its Average True Range was 0.08.
During the past 100 days, Opko Health Inc’s (OPK) raw stochastic average was set at 11.51%, which indicates a significant decrease from 22.86% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.55% in the past 14 days, which was higher than the 40.32% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6767, while its 200-day Moving Average is $1.5489. Now, the first resistance to watch is $1.4400. This is followed by the second major resistance level at $1.4600. The third major resistance level sits at $1.4800. If the price goes on to break the first support level at $1.4000, it is likely to go to the next support level at $1.3800. The third support level lies at $1.3600 if the price breaches the second support level.
Opko Health Inc (NASDAQ: OPK) Key Stats
There are currently 671,550K shares outstanding in the company with a market cap of 953.60 million. Presently, the company’s annual sales total 713,140 K according to its annual income of -53,220 K. Last quarter, the company’s sales amounted to 183,640 K and its income totaled 14,030 K.
